A survey conducted by the Gallup Center and West Health has found that most Americans are comfortable with artificial intelligence playing a role in their healthcare, provided that doctors remain in control. The same survey, however, indicates that physicians are considerably more wary of AI than their patients are. This divergence in attitudes is poised to shape the national conversation around AI in medicine, as stakeholders across the sector grapple with how much decision-making authority should be delegated to machines.
The finding matters because it inverts the usual assumption that patients are the more cautious party when it comes to new medical technology. If patients are more willing to embrace AI-assisted care than the clinicians treating them, healthcare providers may face pressure to adopt AI tools faster than their own comfort levels would dictate. That tension could influence everything from hospital procurement policies to physician training and liability frameworks.
According to the survey, the tasks that AI can or cannot be trusted with are likely to be the subject of increasing debate in the months to come across the healthcare sector. The survey did not specify which tasks patients and doctors view differently, but the broad pattern is clear: patients see AI as an aid, while many doctors appear to see it as a challenge to their judgment. Discussions on the subject are already taking place within sector players such as Astiva Health, a Medicare Advantage plan, suggesting that the industry is not waiting for consensus before exploring AI applications.
The survey’s release comes as AI tools are being deployed across diagnostics, administrative workflows, and patient triage. The gap in trust could slow adoption if doctors resist tools that patients expect, or it could accelerate adoption if health systems prioritize patient preferences. Either way, the survey highlights a communication challenge: clinicians may need to explain their reservations to patients who are already comfortable with AI, and patients may need to understand why their doctors are cautious.
For readers, the survey signals that AI in healthcare is not just a technical or regulatory issue but a human one. Patients’ comfort levels could influence which providers they choose and how they evaluate their care. For the industry, the survey underscores the need for clear guidelines on AI’s role, as well as transparent communication with both patients and physicians. As the debate unfolds, it will likely be covered by outlets and platforms such as BioMedWire, which focuses on developments in biotechnology and life sciences. BioMedWire is one of more than 75 brands within the Dynamic Brand Portfolio at IBN, a communications group that provides wire solutions through InvestorWire and offers editorial syndication to 5,000+ outlets, among other services.
The survey’s findings are a reminder that the adoption of AI in healthcare will depend as much on trust as on technology. With patients and doctors diverging on that trust, the coming months are likely to bring more scrutiny of which AI tasks are acceptable and who gets to decide.


